Table: Sapporo Clinical Lab -9-MTH group results

Sapporo Clinical Laboratory

10/02/2017 06:30

Feb 10 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             12.84               13.13            17.69     
                 (-2.2 pct)          (+3.7 pct)       (+0.9 pct)   
  Operating        547 mln             706 mln          697 mln    
                 (-22.6 pct)         (+19.0 pct)      (-28.4 pct)  
  Recurring        574 mln             723 mln          727 mln    
                 (-20.6 pct)         (+17.7 pct)      (-27.3 pct)  
  Net              373 mln             454 mln          476 mln    
                 (-17.7 pct)         (+23.5 pct)      (-19.4 pct)  
  EPS            107.47 yen          130.65 yen       136.85 yen   
  Ann Div                             11.00 yen        11.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             11.00 yen        11.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))